Imagenomix
New York, US · 2 known investors
Find your way into Imagenomix
Imagenomix develops AI-powered genomic diagnostics for cancer patients, using computational pathology to predict genetic alterations from tissue imagery. The company serves oncologists and pathologists seeking precision medicine insights for clinical decision-making.
Founders & leadership
AT
Aris TsirigosCo-Founder
MS
Matija SnuderlCo-Founder
DO
Daniel OrringerCo-Founder
TW
Travis WoldinChief Executive OfficerHe has held leadership roles in biotech, medical devices, pharmaceuticals, and pathology, with experience spanning product development, commercialization, and sales.
MT
Mikhail TeverovskiyChief Technology Officer
LK
Lizabeth KatsnelsonPrincipal AI Data Scientist
Investors · 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeedMay 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Imagenomix do?
- Imagenomix develops AI-powered genomic diagnostics for cancer patients, using computational pathology to predict genetic alterations from tissue imagery. The company serves oncologists and pathologists seeking precision medicine insights for clinical decision-making.
- Who founded Imagenomix?
- Imagenomix was founded by Aris Tsirigos, Matija Snuderl, Daniel Orringer.
- Who are Imagenomix's investors?
- Imagenomix's investors include Modi Ventures, Verge HealthTech Fund.
- Where is Imagenomix headquartered?
- Imagenomix is headquartered in New York, US.